A fragment of human growth hormone (amino acids 176-191) with fat-burning properties but without growth-promoting effects. Stimulates lipolysis and inhibits lipogenesis without affecting insulin levels. Failed Phase 3 trials for obesity but remains popular in research community.
Dosing & Protocols
300-600mcg/day subcutaneous, often fasted morning. Commonly cycled 8-12 weeks.
Side Effects
Generally well tolerated. Reported: injection site redness, occasional headache.
Interactions & Contraindications
Minimal known interactions. Unlike hGH does not significantly interact with insulin pathways.
Storage
Freeze lyophilized. Refrigerate reconstituted, use within 30 days.
Disclaimer: All information is for research purposes only. Not medical advice.